Delivery Order SPE2DB22D3301-SPE2DB25FZ1GN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,646.19 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on September 17, 2025, with completion scheduled for September 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) valued at $1,603.56. This firm fixed-price delivery order is scheduled for completion by September 22, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,393.55 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,854.29 delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of April 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.24 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a single delivery order issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) valued at $1,063.84 with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order was issued on September 15, 2025, with no set-aside designation. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $3,028.92 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed price contract with performance to be completed by August 26, 2025, at the awardee's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,679.12 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order, awarded without set-aside designation on May 27, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1GNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100-count) valued at $2,642.92 under a firm fixed-price contract type. The award, issued on September 19, 2025, with a completion date of September 22, 2025, represents a non-competitive, non-set-aside transaction. Performance will occur at the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The prime contract enables the company to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor serving federal medical procurement needs, particularly within the military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/19/25 |